Join to View Full Profile
89 French StNew Brunswick, NJ 08901
Phone+1 732-235-4980
Fax+1 732-235-5002
Dr. Horton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Daniel B. Horton, MD, MSCE is a pediatric rheumatologist based in New Brunswick, NJ. He completed his medical education at Harvard Medical School in 2008, followed by a Pediatrics Residency at the Children's Hospital of Philadelphia and a Pediatric Rheumatology Fellowship at Nemours Children's Health in Wilmington, Delaware. Dr. Horton performs research in a variety of areas, including research on juvenile idiopathic arthritis, pediatric medication use and safety, child health, team science, and COVID-19.
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/Nemours Children's Health, WilmingtonFellowship, Pediatric Rheumatology, 2011 - 2014
Children's Hospital of PhiladelphiaResidency, Pediatrics, 2008 - 2011
Harvard Medical SchoolClass of 2008
Certifications & Licensure
NJ State Medical License 2016 - 2025
DE State Medical License 2011 - 2017
PA State Medical License 2008 - 2013
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Rheumatology
Publications & Presentations
PubMed
- Early childhood antibiotics and chronic pediatric conditions: a retrospective cohort study.Matthew A Beier, Soko Setoguchi, Tobias Gerhard, Jason Roy, Dawn Koffman
The Journal of Infectious Diseases. 2025-04-16 - Trends in New Use of Disease-Modifying Antirheumatic Drugs for Juvenile Idiopathic Arthritis Among Commercially Insured Children in the United States from 2001 to 2022.Priyanka Yalamanchili, Lydia Y Lee, Greta Bushnell, Melissa L Mannion, Chintan V Dave
Arthritis & Rheumatology. 2025-04-01 - 1 citationsPediatric Pharmacoepidemiology and Drug Development From a Regulatory Perspective.Ann W McMahon, Daniel B Horton, Yeruk Mulugeta, Lynne Yao
Clinical Pharmacology and Therapeutics. 2025-04-01
Press Mentions
Early Antibiotic Use May Be Linked to Higher Risk of Asthma in Children, Study RevealsApril 22nd, 2025
What Repeated Antibiotic Use Could Be Doing to Your Child's HealthApril 17th, 2025- Antibiotics Might Increase Risk of Childhood Asthma, AllergiesApril 16th, 2025
- Join now to see all
Grant Support
- Safety of Drugs Commonly Used Off-Label in Children Despite Insufficient Evidence of Efficacy and SafetyRUTGERS BIOMEDICAL AND HEALTH SCIENCES2022–2027
- Safety of Drugs Commonly Used Off-Label in Children Despite Insufficient Evidence of Efficacy and SafetyRUTGERS BIOMEDICAL AND HEALTH SCIENCES2022–2027
- New Jersey ECHORUTGERS BIOMEDICAL AND HEALTH SCIENCES2023–2025
- Cohort and biomarkers for COVID-19 severity, natural history, and reinfectionRUTGERS BIOMEDICAL AND HEALTH SCIENCES2021–2025
- Antibiotics, Juvenile Idiopathic Arthritis, and Antirheumatic Treatment ResponseRUTGERS BIOMEDICAL AND HEALTH SCIENCES2019–2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
